Content Management / Subject Areas
Subject Areas
World Pharma Today Journal publishes across 13 subject domains and 98 topics. At submission you nominate one primary topic and up to two secondary topics; the primary topic determines which handling editor takes the manuscript.
Total Subjects
13
Total Topics
98
Article Classification
Primary + Secondary
- 1. Target identification and validation
- 2. Medicinal and pharmaceutical chemistry
- 3. High-throughput and phenotypic screening
- 4. Structure-based and computer-aided drug design
- 5. Lead optimisation and structure–activity relationships
- 6. Natural products and phytopharmaceuticals
- 7. Peptide, oligonucleotide and macrocyclic therapeutics
- 1. Molecular and cellular pharmacology
- 2. Pharmacodynamics and receptor pharmacology
- 3. Neuropharmacology and CNS drug action
- 4. Cardiovascular and metabolic pharmacology
- 5. Immunopharmacology and inflammation
- 6. Oncology pharmacology and chemotherapy
- 7. Antimicrobial, antiviral and antiparasitic pharmacology
- 8. Veterinary pharmacology
- 1. Absorption, distribution, metabolism and excretion
- 2. Drug metabolism and cytochrome P450 enzymology
- 3. Bioavailability and bioequivalence
- 4. Population PK/PD modelling and simulation
- 5. Physiologically based pharmacokinetic (PBPK) modelling
- 6. Drug–drug, drug–food and herb–drug interactions
- 7. Therapeutic drug monitoring
- 1. Preclinical and regulatory toxicology
- 2. Genotoxicity, carcinogenicity and reproductive toxicology
- 3. Organ toxicity
- 4. In vitro models, new approach methodologies and the 3Rs
- 5. Clinical and forensic toxicology
- 6. Impurities, nitrosamines, extractables and leachables
- 7. Occupational exposure limits and containment
- 1. In vivo disease models and target engagement
- 2. Organ-on-chip, organoids and 3D culture systems
- 3. In vivo efficacy and proof-of-concept studies
- 4. Translational imaging and non-invasive readouts
- 5. Biomarkers and companion diagnostics
- 6. Translational study design and first-in-human transition
- 7. Reverse translation and bedside-to-bench research
- 8. Drug repurposing and repositioning
- 9. Reproducibility and preclinical study quality
- 1. Phase I to Phase IV trial design and conduct
- 2. Adaptive, platform, basket and umbrella trials
- 3. Decentralised and hybrid trials
- 4. Real-world evidence and observational research
- 5. Biostatistics, endpoints and clinical data management
- 6. Recruitment, retention and diversity in trial populations
- 7. Good Clinical Practice, site management and monitoring
- 8. Bioethics and informed consent
- 1. Preformulation and solid-state characterisation
- 2. Oral solid dosage form development
- 3. Parenteral, ophthalmic and sterile product formulation
- 4. Nanomedicine, liposomes and lipid nanoparticles
- 5. Controlled, modified and targeted release
- 6. Transdermal, inhalation, nasal and mucosal delivery
- 7. Paediatric, geriatric and patient-centric formulation
- 8. Excipient science and compatibility
- 9. Lyophilisation and freeze-drying
- 1. Monoclonal antibodies and antibody–drug conjugates
- 2. Recombinant proteins, enzymes and hormones
- 3. Vaccines, adjuvants and platforms
- 4. Cell and gene therapy including CAR-T, AAV and CRISPR
- 5. mRNA and nucleic-acid therapeutics
- 6. Biosimilar development, comparability and interchangeability
- 7. Upstream and downstream bioprocessing
- 8. Analytical characterisation of biologics and immunogenicity
- 1. Process development, scale-up and technology transfer
- 2. Continuous manufacturing and process analytical technology
- 3. Aseptic processing, sterilisation and containment
- 4. Quality by Design and process validation
- 5. GMP compliance, auditing and data integrity
- 6. Analytical method development and validation
- 7. Stability testing and shelf-life prediction
- 8. Cleaning validation and contamination control
- 9. Facility design, utilities and single-use systems
- 1. Regulatory affairs, CTD dossiers and submissions
- 2. Global harmonisation across ICH, WHO, FDA, EMA, CDSCO and PMDA
- 3. Pharmacovigilance, signal detection and risk management
- 4. Post-marketing surveillance and risk-management plans
- 5. Pharmaceutical law, intellectual property and patent strategy
- 6. Medical devices and drug–device combination products
- 1. Clinical pharmacy and medication therapy management
- 2. Pharmacoeconomics and health technology assessment
- 3. Adherence, medication safety and patient outcomes
- 4. Market access, pricing and reimbursement
- 5. Antimicrobial stewardship and resistance
- 6. Pharmacogenomics and precision medicine
- 7. Pharmacy education and workforce development
- 1. Artificial intelligence and machine learning in drug discovery
- 2. Digital health, telemedicine and connected devices
- 3. Bioinformatics, cheminformatics and multi-omics
- 4. Pharmaceutical supply chain, logistics and cold chain
- 5. Serialisation, traceability and anti-counterfeiting
- 6. Packaging, labelling and device human factors
- 7. Computer system validation and Pharma 4.0
- 1. Green chemistry and sustainable manufacturing
- 2. Pharmaceuticals in the environment
- 3. Access to medicines and manufacturing in low- and middle-income countries
- 4. Global health, immunisation and outbreak response
- 5. Nutraceuticals, cosmeceuticals and OTC products
- 6. Traditional, herbal and Ayurvedic medicine standardisation
No subjects or topics match your search.
How subjects work
Choosing your topics at submission
- 1 Nominate one primary topic and up to two secondary topics from the 98 numbered topics.
- 2 The primary topic determines which handling editor takes the manuscript.
- 3 Work outside these 13 domains is returned quickly, so you can submit elsewhere without losing time.
- 4 Negative, confirmatory and methodological studies are considered where the study design is sound.
World Pharma Today Journal · Subject & Topic Management